PCM
MRK icon

Prelude Capital Management’s Merck MRK Stock Holding History

Prelude Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,500
Closed -$287K – 1969
2022
Q1 		$287K Sell
3,500
-3,800
-52% -$300K 0.01% 1092
2021
Q4 		$559K Buy
+7,300
New +$581K 0.01% 941
2021
Q2 		– Sell
-6,498
Closed -$478K – 1843
2021
Q1 		$478K Buy
+6,498
New +$479K 0.01% 922
2020
Q4 		– Sell
-105
Closed -$8K – 1721
2020
Q3 		$8K Buy
+105
New +$8.22K ﹤0.01% 1489
2018
Q3 		– Sell
-15,091
Closed -$874K – 1929
2018
Q2 		$874K Buy
+15,091
New +$851K 0.06% 369
2015
Q2 		– Sell
-2,096
Closed -$115K – 1913
2015
Q1 		$115K Buy
+2,096
New +$119K 0.02% 948

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prelude Capital Management's MRK Position: Q1 2026 in Review

Prelude Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 5,023 shares — an estimated $529K sold.

Prelude Capital Management first reported a position in MRK in Q4 2013 and held it in 36 quarters. The position peaked at $2.66M in Q1 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Prelude Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 5,023 Merck shares in Q1 2026, an estimated $529K.
  • Prelude Capital Management first reported a position in Merck in Q4 2013 and held it in 36 quarters.
  • Prelude Capital Management's Merck position peaked at $2.66M in Q1 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.